Round Type
Venture
NorwayBiotechnologyTherapeuticsBiopharmaDescription
Norway Oncoinvent AS, a clinical stage company advancing a pipeline of radiopharmaceutical products across a variety of solid cancers, announced today that the company has raised NOK 250 million in an oversubscribed pre-IPO financing round syndicated by existing investors Hadean Ventures, Geveran, RADFORSK Investeringsstiftelse, Sundt, Must Invest, Canica, MP Pensjon and Watrium. The net proceeds from the Private Placement are expected to ensure financing past end of 2023 for its lead product candidate Radspherin®, including financing of two clinical phase 2A studies (in ovarian cancer and colorectal cancer) as well as the advancement of the company’s proprietary targeted radiotherapy candidates. Oncoinvent has raised a total of NOK 535 million to date. The closing marks the last round of planned funding before Oncoinvent goes to its contemplated initial public offering (IPO) which the intends to carry out in the coming twelve months.
Quick answer
Oncoinvent ASA raised an undisclosed amount in a funding round, dated June 29, 2021. Oncoinvent ASA is based in Norway.
- How much did Oncoinvent ASA raise?
- Oncoinvent ASA raised an undisclosed amount in a funding round on June 29, 2021.
- What does Oncoinvent ASA do?
- Oncoinvent ASA is a clinical-stage biotechnology company developing novel radiopharmaceutical therapies against cancer.
- Where is Oncoinvent ASA based and how big is it?
- Oncoinvent ASA is based in Norway.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biopharma around the same time
Companies in the same sectors as Oncoinvent ASA that raised within 45 days of this round, from Fundz verified event records.
- Arbutus raised $81M on June 23, 2021.
- Camp4 Therapeutics Corp raised $45M (Funding Round) on June 15, 2021.
- Ajax Therapeutics, Inc. raised $37M on June 1, 2021.
- Clene Nanomedicine raised $9.3M on May 26, 2021.
- GentiBio raised $157M (Series A) on August 11, 2021.
- Renovacor, Inc. raised $2.5M (Seed) on August 4, 2021.
Who to call at Oncoinvent ASA, and when
A new round usually means Oncoinvent ASA is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Oncoinvent ASA raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Oncoinvent ASA, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Oncoinvent ASA. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Oncoinvent ASA raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Oncoinvent ASA raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.